Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1996
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2222134A1 Monospecific antibodies against a subunit of fibrinogen
12/19/1996CA2221821A1 Endothelial-monocyte activating polypeptide iii
12/19/1996CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus
12/19/1996CA2220952A1 Anti-allergy bispecific molecules
12/19/1996CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996CA2196691A1 Macrophage derived chemokine and chemokine analogs
12/18/1996EP0748816A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748815A1 Toxoplasma gondii antigen, its production and use
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748338A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
12/18/1996EP0748335A1 Antibiotic stalobacins
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996EP0662147B1 Small cell lung carcinoma specific antibody and antigen
12/18/1996EP0609242B1 New thrombin-inhibiting protein isolated from ticks
12/18/1996EP0504371B1 Hiv diagnostic method and reagent
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138295A A novel tumor suppressor gene
12/18/1996CN1138098A Selection fermentation and extraction technology of brewing yeast metallothionein producing strain
12/17/1996US5585478 D4 gene and methods of use thereof
12/17/1996US5585474 DNA encoding protein possessing metastasis-inhibitory activity
12/17/1996US5585464 Recombinant antigen for diagnosing rheumatoid arthritis
12/17/1996US5585463 β3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides
12/17/1996US5585351 T-cadherin adhesion molecule
12/17/1996US5585350 Thrombin-inhibitory protein from ticks
12/17/1996US5585345 CTP extended form of glycoprotein hormones
12/17/1996US5585257 Genetically engineered yeast cells
12/17/1996US5585250 Hiv-1 vaccine; variations and modifications of the v3 loop including additional glycosylation signals
12/17/1996US5585237 Stable genetically engineered cells containing transfected dna sequences which code for viral transcription promoters and activators
12/17/1996US5585233 Mutant; gebnetic engineering
12/17/1996US5585097 Aglycosylated immunoglobulin g antibody; preventing renal allograft rejection
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996CA2023114C Microorganism for selective production of a specific component of avermectin and a method for selective production thereof
12/17/1996CA2006684C Monoclonal antibody against protein c
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039540A1 Novel gene-up regulated in regenerating liver
12/12/1996WO1996039523A2 Bacterial production of hydrophobic polypeptides
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039519A1 Kunitz type plasma kallikrein inhibitors
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039513A2 Ebnerin cloning of a secreted von ebner's gland protein
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039488A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039484A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996WO1996039172A1 Suppressor of hiv replication and transcription
12/12/1996WO1996039158A1 Pineal gland specific gene-1
12/12/1996WO1996035788A3 Kunitz type protease inhibitors
12/12/1996WO1996020732A3 Non-traumatic administration of gene delivery vehicles
12/12/1996WO1996011951A3 Keratinocyte growth factor analogs
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996DE19530273C1 Monoclonal antibodies specific for cell-surface glyco-protein MGC-24
12/12/1996CA2562211A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223950A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223707A1 Novel gene-up regulated in regenerating liver
12/12/1996CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/11/1996EP0747485A1 Production of proteins using homologous recombination
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides
12/11/1996EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof
12/11/1996EP0747063A2 Neisseria meningitidis capsular polysaccharide conjugates
12/11/1996EP0746626A1 Method for carbohydrate engineering of glycoproteins
12/11/1996EP0746612A1 Synthetic polynucleotides
12/11/1996EP0746611A1 METHOD FOR INCREASING PRODUCTION OF DISULFIDE BONDED RECOMBINANT PROTEINS BY $i(SACCHAROMYCES CEREVISIAE)
12/11/1996EP0746609A1 Transgenic non-human animals capable of producing heterologous antibodies
12/11/1996EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
12/11/1996EP0746565A1 Novel bombesin-related peptides
12/11/1996EP0746398A1 Antibody purification
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1125